Literature DB >> 36123169

Lessons from COVID-19 to increase opioid vaccine acceptance.

Roxana Damiescu1, Mita Banerjee2, Norbert W Paul3, Thomas Efferth4.   

Abstract

COVID-19 has put vaccine efficacy under a spotlight. However, the reluctance of people to be vaccinated has postponed the end of the COVID-19 pandemic. Currently, opioid vaccines are being developed, which could help prevent opioid addiction, overdoses, or relapse in combination with medication-assisted therapy. The fear is that the uptake of opioid vaccines could be met by the same reluctance as seen with COVID-19 vaccines.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COVID-19 vaccination; opioid misuse; opioid vaccination; public health; vaccine reluctance

Year:  2022        PMID： 36123169      PMCID： PMC9448697          DOI： 10.1016/j.tips.2022.08.010

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   17.638


  7 in total

1.  COVID-19, mental health, and opioid use disorder: Old and new public health crises intertwine.

Authors:  Brandy F Henry; Amar D Mandavia; Margaret M Paschen-Wolff; Timothy Hunt; Jennifer L Humensky; Elwin Wu; Harold A Pincus; Edward V Nunes; Frances R Levin; Nabila El-Bassel
Journal:  Psychol Trauma       Date:  2020-06-18

Review 2.  Development of vaccines to treat opioid use disorders and reduce incidence of overdose.

Authors:  Marco Pravetoni; Sandra D Comer
Journal:  Neuropharmacology       Date:  2019-06-04       Impact factor: 5.250

Review 3.  Critical Care Pain Management in Patients Affected by the Opioid Epidemic: A Review.

Authors:  Kunal Karamchandani; Zyad J Carr; Anthony Bonavia; Avery Tung
Journal:  Ann Am Thorac Soc       Date:  2018-09

4.  Opioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data.

Authors:  Fares Qeadan; Benjamin Tingey; Rona Bern; Christina A Porucznik; Kevin English; Ali I Saeed; Erin Fanning Madden
Journal:  EClinicalMedicine       Date:  2021-06-04

5.  Trust in a COVID-19 vaccine among people with substance use disorders.

Authors:  Alexandra M Mellis; Braeden C Kelly; Marc N Potenza; Jessica N Hulsey
Journal:  Drug Alcohol Depend       Date:  2021-01-11       Impact factor: 4.492

6.  Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021.

Authors:  Lindsey Wang; QuanQiu Wang; Pamela B Davis; Nora D Volkow; Rong Xu
Journal:  World Psychiatry       Date:  2021-10-05       Impact factor: 79.683

7.  COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.

Authors:  Quan Qiu Wang; David C Kaelber; Rong Xu; Nora D Volkow
Journal:  Mol Psychiatry       Date:  2020-09-14       Impact factor: 15.992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.